Skip to main content
Erschienen in:

11.08.2023 | Original Contributions

Diagnostic Performance of 2D Shear Wave (2D-SWE) for Liver Fibrosis in Adults Undergoing Bariatric Surgery

verfasst von: Ana L. Alcantara-Diaz, Jaime F. Ruiz-Fernandez, Jorge L. Salazar-Alarcon, Gustavo Salinas-Sedo, Carlos J. Toro-Huamanchumo

Erschienen in: Obesity Surgery | Ausgabe 10/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

Among the most recent methods to diagnose liver fibrosis is 2D shear wave elastography (2D-SWE). However, the evidence in the Latin population is limited, and there is no consensus on the cutoff points for each stage of fibrosis.

Aim

To evaluate the diagnostic performance of 2D-SWE for liver fibrosis in adults with obesity who underwent bariatric surgery (BS).

Methods

We conducted a cross-sectional study on patients with obesity who underwent BS between 2020 and 2021. Liver stiffness measurement was reported as the mean of valid measurements in kilopascals made with the 2D-SWE. The outcome was biopsy-proven liver fibrosis. ROC curves were constructed for significant fibrosis (F≥2) and advanced fibrosis (F≥3), with their respective area under the curve (AUC). To obtain the best cutoff point for each scenario, we used the Youden index. The 95% confidence intervals (95% CI) for each cutoff point were estimated by bootstrap with 1000 replications.

Results

We analyzed data from 227 patients. The mean age was 37.8 ± 11.1 years and 65.2% were women. Overall, the AUC for significant and advanced fibrosis was 0.54 (95% CI: 0.47–0.62) and 0.73 (95% CI: 0.60–0.87), respectively. For advanced fibrosis, higher AUCs were found among women (AUC: 0.82; 95% CI: 0.59–1.00) and among patients with morbid obesity (AUC: 0.78; 95% CI: 0.61–0.99).

Conclusion

The 2D-SWE appears to be a valuable tool for screening advanced liver fibrosis in candidates for BS, mainly in the female population and in adults with morbid obesity.

Graphical Abstract

Literatur
1.
Zurück zum Zitat Silva MBBE, Tustumi F, Dantas ACB, Miranda BCJ, Pajecki D, De-Cleva R, et al. Obesity and severe steatosis: the importance of biochemical exams and scores. Arq Bras Cir Dig ABCD. 2021;34(4):e1626.CrossRef Silva MBBE, Tustumi F, Dantas ACB, Miranda BCJ, Pajecki D, De-Cleva R, et al. Obesity and severe steatosis: the importance of biochemical exams and scores. Arq Bras Cir Dig ABCD. 2021;34(4):e1626.CrossRef
2.
Zurück zum Zitat Kyle TK, Dhurandhar EJ, Allison DB. Regarding obesity as a disease: evolving policies and their implications. Endocrinol Metab Clin North Am. 2016;45(3):511–20.PubMedPubMedCentralCrossRef Kyle TK, Dhurandhar EJ, Allison DB. Regarding obesity as a disease: evolving policies and their implications. Endocrinol Metab Clin North Am. 2016;45(3):511–20.PubMedPubMedCentralCrossRef
3.
Zurück zum Zitat Luo Y, Lin H. Inflammation initiates a vicious cycle between obesity and nonalcoholic fatty liver disease. Immun Inflamm Dis. 2021;9(1):59–73.PubMedCrossRef Luo Y, Lin H. Inflammation initiates a vicious cycle between obesity and nonalcoholic fatty liver disease. Immun Inflamm Dis. 2021;9(1):59–73.PubMedCrossRef
4.
Zurück zum Zitat Hashem A, Khalouf A, Acosta A. Management of obesity and nonalcoholic fatty liver disease: a literature review. Semin Liver Dis. 2021;41(4):435–47.PubMedPubMedCentralCrossRef Hashem A, Khalouf A, Acosta A. Management of obesity and nonalcoholic fatty liver disease: a literature review. Semin Liver Dis. 2021;41(4):435–47.PubMedPubMedCentralCrossRef
5.
Zurück zum Zitat Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatol Baltim Md. 2018;67(1):328–57.CrossRef Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatol Baltim Md. 2018;67(1):328–57.CrossRef
6.
Zurück zum Zitat Liu A, Galoosian A, Kaswala D, Li AA, Gadiparthi C, Cholankeril G, et al. Nonalcoholic fatty liver disease: epidemiology, liver transplantation trends and outcomes, and risk of recurrent disease in the graft. J Clin Transl Hepatol. 2018;6(4):420–4.PubMedPubMedCentral Liu A, Galoosian A, Kaswala D, Li AA, Gadiparthi C, Cholankeril G, et al. Nonalcoholic fatty liver disease: epidemiology, liver transplantation trends and outcomes, and risk of recurrent disease in the graft. J Clin Transl Hepatol. 2018;6(4):420–4.PubMedPubMedCentral
7.
Zurück zum Zitat Diehl AM, Day C. Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis. N Engl J Med. 2017;377(21):2063–72.PubMedCrossRef Diehl AM, Day C. Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis. N Engl J Med. 2017;377(21):2063–72.PubMedCrossRef
8.
Zurück zum Zitat Angulo P, Kleiner DE, Dam-Larsen S, Adams LA, Bjornsson ES, Charatcharoenwitthaya P, et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2015;149(2):389–397.e10.PubMedCrossRef Angulo P, Kleiner DE, Dam-Larsen S, Adams LA, Bjornsson ES, Charatcharoenwitthaya P, et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2015;149(2):389–397.e10.PubMedCrossRef
9.
Zurück zum Zitat Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, Torres-Gonzalez A, Gra-Oramas B, Gonzalez-Fabian L, et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology. 2015;149(2):367–378.e5.PubMedCrossRef Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, Torres-Gonzalez A, Gra-Oramas B, Gonzalez-Fabian L, et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology. 2015;149(2):367–378.e5.PubMedCrossRef
10.
Zurück zum Zitat Głuszyńska P, Lemancewicz D, Dzięcioł JB, Razak HH. Non-alcoholic fatty liver disease (NAFLD) and bariatric/metabolic surgery as its treatment option: a review. J Clin Med. 2021;10(24):5721.PubMedPubMedCentralCrossRef Głuszyńska P, Lemancewicz D, Dzięcioł JB, Razak HH. Non-alcoholic fatty liver disease (NAFLD) and bariatric/metabolic surgery as its treatment option: a review. J Clin Med. 2021;10(24):5721.PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Cobbina E, Akhlaghi F. Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters. Drug Metab Rev. 2017;49(2):197–211.PubMedPubMedCentralCrossRef Cobbina E, Akhlaghi F. Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters. Drug Metab Rev. 2017;49(2):197–211.PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Garg H, Aggarwal S, Shalimar, et al. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients. Surg Obes Relat Dis Off J Am Soc Bariatr Surg. 2018;14(1):81–91.CrossRef Garg H, Aggarwal S, Shalimar, et al. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients. Surg Obes Relat Dis Off J Am Soc Bariatr Surg. 2018;14(1):81–91.CrossRef
13.
Zurück zum Zitat Imajo K, Kessoku T, Honda Y, Tomeno W, Ogawa Y, Mawatari H, et al. Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography. Gastroenterology. 2016;150(3):626–637.e7.PubMedCrossRef Imajo K, Kessoku T, Honda Y, Tomeno W, Ogawa Y, Mawatari H, et al. Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography. Gastroenterology. 2016;150(3):626–637.e7.PubMedCrossRef
14.
Zurück zum Zitat Herrmann E, de Lédinghen V, Cassinotto C, Chu WCW, Leung VYF, Ferraioli G, et al. Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: an individual patient data-based meta-analysis. Hepatol Baltim Md. 2018;67(1):260–72.CrossRef Herrmann E, de Lédinghen V, Cassinotto C, Chu WCW, Leung VYF, Ferraioli G, et al. Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: an individual patient data-based meta-analysis. Hepatol Baltim Md. 2018;67(1):260–72.CrossRef
15.
Zurück zum Zitat Bedossa P, Poitou C, Veyrie N, Bouillot JL, Basdevant A, Paradis V, et al. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. Hepatology. 2012;56(5):1751–9.PubMedCrossRef Bedossa P, Poitou C, Veyrie N, Bouillot JL, Basdevant A, Paradis V, et al. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. Hepatology. 2012;56(5):1751–9.PubMedCrossRef
16.
Zurück zum Zitat Singh S, Muir AJ, Dieterich DT, Falck-Ytter YT. American Gastroenterological Association Institute technical review on the role of elastography in chronic liver diseases. Gastroenterology. 2017;152(6):1544–77.PubMedCrossRef Singh S, Muir AJ, Dieterich DT, Falck-Ytter YT. American Gastroenterological Association Institute technical review on the role of elastography in chronic liver diseases. Gastroenterology. 2017;152(6):1544–77.PubMedCrossRef
17.
Zurück zum Zitat Castera L, Friedrich-Rust M, Loomba R. Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology. abril de. 2019;156(5):1264–1281.e4.CrossRef Castera L, Friedrich-Rust M, Loomba R. Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology. abril de. 2019;156(5):1264–1281.e4.CrossRef
18.
Zurück zum Zitat Cassinotto C, Boursier J, de Lédinghen V, et al. Liver stiffness in nonalcoholic fatty liver disease: a comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy. Hepatol Baltim Md. 2016;63(6):1817–27.CrossRef Cassinotto C, Boursier J, de Lédinghen V, et al. Liver stiffness in nonalcoholic fatty liver disease: a comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy. Hepatol Baltim Md. 2016;63(6):1817–27.CrossRef
19.
Zurück zum Zitat Park CC, Nguyen P, Hernandez C, et al. Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease. Gastroenterology. 2017;152(3):598–607.e2.PubMedCrossRef Park CC, Nguyen P, Hernandez C, et al. Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease. Gastroenterology. 2017;152(3):598–607.e2.PubMedCrossRef
20.
Zurück zum Zitat Fu J, Wu B, Wu H, Lin F, Deng W. Accuracy of real-time shear wave elastography in staging hepatic fibrosis: a meta-analysis. BMC Med Imaging. 2020;20(1):16.PubMedPubMedCentralCrossRef Fu J, Wu B, Wu H, Lin F, Deng W. Accuracy of real-time shear wave elastography in staging hepatic fibrosis: a meta-analysis. BMC Med Imaging. 2020;20(1):16.PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Furlan A, Tublin ME, Yu L, Chopra KB, Lippello A, Behari J. Comparison of 2D shear wave elastography, transient elastography, and MR elastography for the diagnosis of fibrosis in patients with nonalcoholic fatty liver disease. AJR Am J Roentgenol. 2020;214(1):W20–6.PubMedCrossRef Furlan A, Tublin ME, Yu L, Chopra KB, Lippello A, Behari J. Comparison of 2D shear wave elastography, transient elastography, and MR elastography for the diagnosis of fibrosis in patients with nonalcoholic fatty liver disease. AJR Am J Roentgenol. 2020;214(1):W20–6.PubMedCrossRef
22.
Zurück zum Zitat Jamialahmadi T, Nematy M, Jangjoo A, Goshayeshi L, Rezvani R, Ghaffarzadegan K, et al. Measurement of liver stiffness with 2D-shear wave elastography (2D-SWE) in bariatric surgery candidates reveals acceptable diagnostic yield compared to liver biopsy. Obes Surg. 2019;29(8):2585–92.PubMedCrossRef Jamialahmadi T, Nematy M, Jangjoo A, Goshayeshi L, Rezvani R, Ghaffarzadegan K, et al. Measurement of liver stiffness with 2D-shear wave elastography (2D-SWE) in bariatric surgery candidates reveals acceptable diagnostic yield compared to liver biopsy. Obes Surg. 2019;29(8):2585–92.PubMedCrossRef
23.
Zurück zum Zitat Jamialahmadi T, Jangjoo A, Rezvani R, Goshayeshi L, Tasbandi A, Nooghabi MJ, et al. Hepatic function and fibrosis assessment via 2D-shear wave elastography and related biochemical markers pre- and post-gastric bypass surgery. Obes Surg. 2020;30(6):2251–8.PubMedCrossRef Jamialahmadi T, Jangjoo A, Rezvani R, Goshayeshi L, Tasbandi A, Nooghabi MJ, et al. Hepatic function and fibrosis assessment via 2D-shear wave elastography and related biochemical markers pre- and post-gastric bypass surgery. Obes Surg. 2020;30(6):2251–8.PubMedCrossRef
24.
Zurück zum Zitat Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatol Baltim Md. 2005;41(6):1313–21.CrossRef Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatol Baltim Md. 2005;41(6):1313–21.CrossRef
25.
Zurück zum Zitat Li C, Zhang C, Li J, Huo H, Song D. Diagnostic accuracy of real-time shear wave elastography for staging of liver fibrosis: a meta-analysis. Med Sci Monit Int Med J Exp. Clin Res. 2016;22:1349–59. Li C, Zhang C, Li J, Huo H, Song D. Diagnostic accuracy of real-time shear wave elastography for staging of liver fibrosis: a meta-analysis. Med Sci Monit Int Med J Exp. Clin Res. 2016;22:1349–59.
26.
Zurück zum Zitat Paul SB, Das P, Mahanta M, Sreenivas V, Kedia S, Kalra N, et al. Assessment of liver fibrosis in chronic hepatitis: comparison of shear wave elastography and transient elastography. Abdom Radiol N Y. diciembre de. 2017;42(12):2864–73.CrossRef Paul SB, Das P, Mahanta M, Sreenivas V, Kedia S, Kalra N, et al. Assessment of liver fibrosis in chronic hepatitis: comparison of shear wave elastography and transient elastography. Abdom Radiol N Y. diciembre de. 2017;42(12):2864–73.CrossRef
28.
Zurück zum Zitat Jang JK, Lee ES, Seo JW, Kim YR, Kim SY, Cho YY, et al. Two-dimensional shear-wave elastography and US attenuation imaging for nonalcoholic steatohepatitis diagnosis: a cross-sectional, multicenter study. Radiology. 2022;305(1):118–26.PubMedCrossRef Jang JK, Lee ES, Seo JW, Kim YR, Kim SY, Cho YY, et al. Two-dimensional shear-wave elastography and US attenuation imaging for nonalcoholic steatohepatitis diagnosis: a cross-sectional, multicenter study. Radiology. 2022;305(1):118–26.PubMedCrossRef
29.
Zurück zum Zitat Jiang T, Tian G, Zhao Q, Kong D, Cheng C, Zhong L, et al. Diagnostic accuracy of 2D-shear wave elastography for liver fibrosis severity: a meta-analysis. PLoS One. 2016;11(6):e0157219.PubMedPubMedCentralCrossRef Jiang T, Tian G, Zhao Q, Kong D, Cheng C, Zhong L, et al. Diagnostic accuracy of 2D-shear wave elastography for liver fibrosis severity: a meta-analysis. PLoS One. 2016;11(6):e0157219.PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat Parikh NS, Koh I, VanWagner LB, Elkind MSV, Zakai NA, Cushman M. Liver fibrosis is associated with ischemic stroke risk in women but not men: the REGARDS study. J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc. 2021;30(7):105788.CrossRef Parikh NS, Koh I, VanWagner LB, Elkind MSV, Zakai NA, Cushman M. Liver fibrosis is associated with ischemic stroke risk in women but not men: the REGARDS study. J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc. 2021;30(7):105788.CrossRef
31.
Zurück zum Zitat Klair JS, Yang JD, Abdelmalek MF, Guy CD, Gill RM, Yates K, et al. A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease. Hepatol Baltim Md. 2016;64(1):85–91.CrossRef Klair JS, Yang JD, Abdelmalek MF, Guy CD, Gill RM, Yates K, et al. A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease. Hepatol Baltim Md. 2016;64(1):85–91.CrossRef
32.
Zurück zum Zitat Yang JD, Abdelmalek MF, Pang H, Guy CD, Smith AD, Diehl AM, et al. Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis. Hepatol Baltim Md. 2014;59(4):1406–14.CrossRef Yang JD, Abdelmalek MF, Pang H, Guy CD, Smith AD, Diehl AM, et al. Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis. Hepatol Baltim Md. 2014;59(4):1406–14.CrossRef
33.
Zurück zum Zitat Landgren BM, Collins A, Csemiczky G, Burger HG, Baksheev L, Robertson DM. Menopause transition: annual changes in serum hormonal patterns over the menstrual cycle in women during a nine-year period prior to menopause. J Clin Endocrinol Metab. 2004;89(6):2763–9.PubMedCrossRef Landgren BM, Collins A, Csemiczky G, Burger HG, Baksheev L, Robertson DM. Menopause transition: annual changes in serum hormonal patterns over the menstrual cycle in women during a nine-year period prior to menopause. J Clin Endocrinol Metab. 2004;89(6):2763–9.PubMedCrossRef
34.
35.
Zurück zum Zitat Thaung Zaw JJ, Howe PRC, Wong RHX. Postmenopausal health interventions: time to move on from the Women’s Health Initiative? Ageing Res Rev. 2018;48:79–86.PubMedCrossRef Thaung Zaw JJ, Howe PRC, Wong RHX. Postmenopausal health interventions: time to move on from the Women’s Health Initiative? Ageing Res Rev. 2018;48:79–86.PubMedCrossRef
36.
Zurück zum Zitat Razmjou S, Abdulnour J, Bastard JP, Fellahi S, Doucet É, Brochu M, et al. Body composition, cardiometabolic risk factors, physical activity, and inflammatory markers in premenopausal women after a 10-year follow-up: a MONET study. Menopause N Y N. 2018;25(1):89–97.CrossRef Razmjou S, Abdulnour J, Bastard JP, Fellahi S, Doucet É, Brochu M, et al. Body composition, cardiometabolic risk factors, physical activity, and inflammatory markers in premenopausal women after a 10-year follow-up: a MONET study. Menopause N Y N. 2018;25(1):89–97.CrossRef
37.
Zurück zum Zitat Ferraioli G, Wong VWS, Castera L, Berzigotti A, Sporea I, Dietrich CF, et al. Liver ultrasound elastography: an update to the World Federation for Ultrasound in Medicine and Biology guidelines and recommendations. Ultrasound Med Biol. 2018;44(12):2419–40.PubMedCrossRef Ferraioli G, Wong VWS, Castera L, Berzigotti A, Sporea I, Dietrich CF, et al. Liver ultrasound elastography: an update to the World Federation for Ultrasound in Medicine and Biology guidelines and recommendations. Ultrasound Med Biol. 2018;44(12):2419–40.PubMedCrossRef
38.
Zurück zum Zitat Zhang YN, Fowler KJ, Boehringer AS, Montes V, Schlein AN, Covarrubias Y, et al. Comparative diagnostic performance of ultrasound shear wave elastography and magnetic resonance elastography for classifying fibrosis stage in adults with biopsy-proven nonalcoholic fatty liver disease. Eur Radiol. 2022;32(4):2457–69.PubMedCrossRef Zhang YN, Fowler KJ, Boehringer AS, Montes V, Schlein AN, Covarrubias Y, et al. Comparative diagnostic performance of ultrasound shear wave elastography and magnetic resonance elastography for classifying fibrosis stage in adults with biopsy-proven nonalcoholic fatty liver disease. Eur Radiol. 2022;32(4):2457–69.PubMedCrossRef
39.
Zurück zum Zitat Sharpton SR, Tamaki N, Bettencourt R, et al. Diagnostic accuracy of two-dimensional shear wave elastography and transient elastography in nonalcoholic fatty liver disease. Ther Adv Gastroenterol. 2021;14:17562848211050436.CrossRef Sharpton SR, Tamaki N, Bettencourt R, et al. Diagnostic accuracy of two-dimensional shear wave elastography and transient elastography in nonalcoholic fatty liver disease. Ther Adv Gastroenterol. 2021;14:17562848211050436.CrossRef
40.
Zurück zum Zitat Selvaraj EA, Mózes FE, Jayaswal ANA, et al. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis. J Hepatol. 2021;75(4):770–85.PubMedCrossRef Selvaraj EA, Mózes FE, Jayaswal ANA, et al. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis. J Hepatol. 2021;75(4):770–85.PubMedCrossRef
41.
Zurück zum Zitat Yoon K, Jeong WK, Kim Y, et al. 2-dimensional shear wave elastography: interobserver agreement and factors related to interobserver discrepancy. PLoS One. 2017;12(4):e0175747.PubMedPubMedCentralCrossRef Yoon K, Jeong WK, Kim Y, et al. 2-dimensional shear wave elastography: interobserver agreement and factors related to interobserver discrepancy. PLoS One. 2017;12(4):e0175747.PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatol Baltim Md. 2016;64(1):73–84.CrossRef Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatol Baltim Md. 2016;64(1):73–84.CrossRef
43.
Zurück zum Zitat Cotter TG, Rinella M. Nonalcoholic fatty liver disease 2020: the state of the disease. Gastroenterology. 2020;158(7):1851–64.PubMedCrossRef Cotter TG, Rinella M. Nonalcoholic fatty liver disease 2020: the state of the disease. Gastroenterology. 2020;158(7):1851–64.PubMedCrossRef
44.
Zurück zum Zitat Vilar-Gomez E, Calzadilla-Bertot L, Wai-Sun Wong V, Castellanos M, Aller-de la Fuente R, Metwally M, et al. Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi-national cohort study. Gastroenterology. 2018;155(2):443–457.e17.PubMedCrossRef Vilar-Gomez E, Calzadilla-Bertot L, Wai-Sun Wong V, Castellanos M, Aller-de la Fuente R, Metwally M, et al. Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi-national cohort study. Gastroenterology. 2018;155(2):443–457.e17.PubMedCrossRef
Metadaten
Titel
Diagnostic Performance of 2D Shear Wave (2D-SWE) for Liver Fibrosis in Adults Undergoing Bariatric Surgery
verfasst von
Ana L. Alcantara-Diaz
Jaime F. Ruiz-Fernandez
Jorge L. Salazar-Alarcon
Gustavo Salinas-Sedo
Carlos J. Toro-Huamanchumo
Publikationsdatum
11.08.2023
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 10/2023
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-023-06766-1

Neu im Fachgebiet Chirurgie

Mit Lidocain kommt der Darm nicht schneller in Schwung

Verzögertes Wiederanspringen der Darmfunktion ist ein Hauptfaktor dafür, wenn Patientinnen und Patienten nach einer Kolonresektion länger als geplant im Krankenhaus bleiben müssen. Ob man diesem Problem mit Lidocain vorbeugen kann, war Thema einer Studie.

Kein Unterschied bei inadäquaten Schocks zwischen ICD-Typen

Inadäquate Schockabgaben sind ein unerwünschter Effekt der Therapie mit implantierbaren Kardioverter-Defibrillatoren. Subkutanen Geräten haftet dabei der Ruf an, dafür besonders anfällig zu sein. Die PRAETORIAN-Forschungsgruppe ist dem nachgegangen.

DCIS: Ist ein Verzicht auf eine Operation möglich?

Die COMET-Studie zeigt, dass aktives Monitoring bei Patientinnen mit duktalem Carcinoma in situ (DCIS) hinsichtlich der kumulativen Zwei-Jahres-Rate an ipsilateralen invasiven Karzinomen der leitliniengerechten Standardbehandlung nicht unterlegen ist. Dennoch wird von einem Verzicht auf eine Operation abgeraten, wie in einem begleitenden Editorial betont wird.

Soll man bei Cholezystektomie routinemäßig cholangiografieren?

Eine US-Studie scheint den Befürwortern einer routinemäßigen intraoperativen Cholangiografie im Rahmen einer Cholezystektomie Recht zu geben. Die Studienkommentatoren in JAMA Surgery sparen jedoch nicht mit Kritik.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.